PHARMINOGEN INC
Contact Information
Company name: PHARMINOGEN INC
Company address: A 1213 767 SINSU-RO SUJI-GU 16827 YONGIN-SI 41, KOR
Partner Overview
Pharminogen has secured five pipelines with AI deep learning patented business models such as innovative new drug development, new drug development consulting, and bioactive material discovery. Also, as an early technology strategy
By securing stable growth potential, business revitalization and technology optimization were realized. Discovery of a number of new drug candidates using methods such as artificial intelligence, machine learning, and structure-based research. Business growth, such as platform construction and technology transfer through commercialization, is an achievement of the last 5 years, and the advancement of technology patents within the next 5 years has led to globalization. In order to secure a competitive edge, we will strategically promote innovative R&D reinvestment, recruitment of talent, and long-term service modeling in the business area.
파미노젠은 혁신 신약개발, 신약개발 컨설팅, 생리활성 소재발굴 등의 비즈니스 모델을 AI 딥러닝 특허기술로 5개의 파이프라인을 확보하였다. 또한 조기 기술전략으로 안정적인 성장
Partner Highlights
- Reselling, Implementation, and Training
Pharminogen is a leading material discovery company for high-speed global innovative new drugs based on artificial intelligence, and is in close collaboration with hospitals and pharmaceutical companies, and AI deep learning-based patent technology by discovering and commercializing natural materials in the fields of life, health, and beauty as well as new drugs. Is being used and applied in various fields. Pharminogen, which is building a stable foundation through technology transfer of innovative new drugs, is promoting global advancement in the fields of innovative new drugs, functional materials, and health and beauty. It aims to increase profits.
파미노젠은 인공지능 기반 초고속 글로벌 혁신신약 선도물질 발굴기업으로 병원과, 제약사 등과 긴밀한 협업을 진행하고 있으며, 신약뿐만 아니라 생활, 건강, 미용분야의 천연물 소재 발굴 및 제품화로 AI 딥러닝 기반 특허 기술을 다양한 분야에 활용, 적용하고 있다. 혁신신약의 국내기업의 기술이전으로 안정적 기반을 다져가고 있는 파미노젠은 혁신신약, 기능성 소재 생활, 건강 미용분야의 글로벌 진출을 추진하고 있으며, IPO 추진으로 제품군 확대를 통한 비즈니스 모델 및 영역확장을 통한 수익상승에 집중적인 목표를 두고 있다.